← Back to Clinical Trials
Recruiting NCT07172568

Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Elbow Tendinopathy
Sponsor Technical University of Munich
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2021-08-25
Completion 2025-12-31
Interventions
Blood Flow Restrictionsham-Blood Flow Restriction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.

Eligibility Criteria

Inclusion Criteria: * diagnosis of lateral epicondylitis * duration of symptoms \> 6 weeks * failed physical therapy * absence of x-ray abnormalities * written and informed consent Exclusion Criteria: * prior joint infiltrations * duration of symptoms \> 12 months * concomitant rheumatoid diseases * concomitant elbow pathologies, including medial epicondylitis * concomitant radicular symptoms of the cervical spine, shoulder or hand * traumatic etiology of symptoms

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE ELBOW TENDINOPATHY TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}